Literature DB >> 1165597

Identification of early adenovirus type 2 RNA species transcribed from the left-hand end of the genome.

E A Craig, M McGrogan, C Mulder, H J Raskas.   

Abstract

Unique fragments of adenovirus type 2 DNA generated by cleavage with endonuclease R-Eco RI or endonuclease R-Hsu I (Hin dIII) were used to map cytoplasmic viral RNAs transcribed early in productive infection. Radioactive early viral RNA was first fractionated by polyacrylamide gel electrophoresis. Eluted viral RNAs were then tested for hybrid formation with DNA fragments. The Eco RI DNA fragment (Eco RI-A) which contains the left-hand 58% of the genome hybridized 13S and 11S RNAs. More detailed mapping of these RNAs was achieved by hybridization to the seven Hsu I fragments of Eco RI-A. The early RNA annealed only to Hsu I-G and C, two fragments which comprise the extreme left-hand 17% of the genome. Viral RNA migrating as 13S and 11S annealed to Hsu I-G, and 13S RNA annealed to Hsu I-C. A 13S RNA is transcribed from Eco RI-A late in infection (18 h). Hybridization-inhibition studies with Eco RI-A DNA, early cytoplasmic RNA, and 3H-labeled 13S late RNA demonstrated that this RNA synthesized at late times is an early RNA species which continues to be synthesized in large amounts at 18 h. This 13S RNA synthesized at 18 h hybridized to Hsu I-C but not to Hsu I-G DNA. These results establish that the 13S RNAs transcribed from Hsu I-G and C at early times must be different species.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165597      PMCID: PMC354752     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  RNA synthesis and processing in adenovirus-infected cells.

Authors:  L Philipson; U Pettersson; U Lindberg; C Tibbetts; B Vennström; T Persson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;.

Authors:  P H Gallimore
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

3.  Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis.

Authors:  P A Sharp; B Sugden; J Sambrook
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

4.  Specificity of the break produced by restricting endonuclease R 1 in Simian virus 40 DNA, as revealed by partial denaturation mapping.

Authors:  C Mulder; H Delius
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

5.  Presence of cell and virus specific sequences in the same molecules of nuclear RNA from virus transformed cells.

Authors:  R Wall; J E Darnell
Journal:  Nat New Biol       Date:  1971-07-21

Review 6.  Oncogenic viruses.

Authors:  M Green
Journal:  Annu Rev Biochem       Date:  1970       Impact factor: 23.643

7.  Synthesis of virus-specific ribonucleic acid in KB cells infected with type 2 adenovirus.

Authors:  J J Lucas; H S Ginsberg
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

8.  Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells.

Authors:  J T Parsons; M Green
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

9.  Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus.

Authors:  M J Ensinger; H S Ginsberg
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

10.  Localization of adenovirus 2 messenger RNA's to segments of the viral genome defined by endonuclease R-R1.

Authors:  J Tal; E A Craig; S Zimmer; H J Raskas
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  10 in total

1.  Possible role of the 72,000 dalton DNA-binding protein in regulation of adenovirus type 5 early gene expression.

Authors:  T H Carter; R A Blanton
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

2.  Genome expression and mRNA maturation at late stages of productive adenovirus type 2 infection.

Authors:  W S Wold; M Green; K H Brackmann; M A Cartas; C Devine
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

3.  mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells.

Authors:  G Chinnadurai; H M Rho; R B Horton; M Green
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

4.  Species identification and genome mapping of cytoplasmic adenovirus type 2 RNAs synthesized late in infection.

Authors:  M McGrogan; H J Raskas
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

5.  Detection of adenovirus type 2-induced early polypeptides using cycloheximide pretreatment to enhance viral protein synthesis.

Authors:  M L Harter; G Shanmugam; W S Wold; M Green
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

6.  Multiple methylated cap sequences in adenovirus type 2 early mRNA.

Authors:  S I Hashimoto; M Green
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

7.  Effect of protein synthesis inhibitors on viral mRNA's synthesized early in adenovirus type 2 infection.

Authors:  F Eggerding; H J Raskas
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  Adenovirus type 2 mRNA in transformed cells: map positions and difference in transport time.

Authors:  M C Wilson; S G Sawicki; M Salditt-Georgieff; J E Darnell
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

9.  Two "early" mRNA species in adenovirus type 2-transformed rat cells.

Authors:  S J Flint
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

10.  Early gene expression of adenovirus type 2: R-loop mapping of mRNA and time course of viral DNA, mRNA, and protein synthesis.

Authors:  P D Neuwald; J Meyer; J V Maizel; H Westpahl
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.